Instant Download
Your unique download link appears right after you complete your purchase, and is also sent instantly to the email address you provided.
Couldn't load pickup availability
Your unique download link appears right after you complete your purchase, and is also sent instantly to the email address you provided.
9783030740276
Springer
2021
English
302
by Anne C. Chiang (Author) Lung cancer has seen a paradigm shift in disease treatment over the past few years, with major changes in the therapeutic drugs now available as well as in the overall management approach. For targeted and immunotherapeutic approaches, understanding the biology of acquired resistance is a key strategy that has yielded productive advances in the subsequent treatment. Future advances also include incorporating biomarker data obtained from solid and liquid biopsies, as well as combination of immunotherapy with radiotherapy and in special populations such patients with CNS involvement. Product Details Publisher: Springer International Publishing; September 30, 2021 Language: English ISBN: 978-3030740276 ISBN: 9783030740276 eText ISBN: 9783030740283
